Boris Kubuschok
Augsburg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease.
Journal: Leukemia & lymphoma
Published: August 02, 2026
Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP.
Journal: Annals of hematology
Published: February 29, 2024
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial.
Journal: Nature communications
Published: April 05, 2023
REFLECT: prospective multicenter non-interventional study evaluating the effectiveness and safety of Sandoz rituximab (SDZ-RTX; Rixathon®) in combination with CHOP for the treatment of patients with previously untreated CD20-positive diffuse large B-cell lymphoma.
Journal: Therapeutic advances in hematology
Published: July 20, 2022
B-cell receptors of EBV-negative Burkitt lymphoma bind modified isoforms of autoantigens.
Journal: EJHaem
Published: March 14, 2022
Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma.
Journal: Haematologica
Published: October 28, 2019
Periodic fever and pancytopenia in a 35-year-old patient
Journal: Der Internist
Published: September 25, 2019
Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development.
Journal: Expert opinion on drug discovery
Published: May 13, 2017
Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor.
Journal: The Journal of clinical investigation
Published: May 02, 2015
Management of diffuse large B-cell lymphoma (DLBCL).
Journal: Cancer treatment and research
Published: February 07, 2015
Autoantibodies against lamin C, NA14 and CK15 in primary vasculitides or autoimmune diseases with secondary vasculitis.
Journal: Clinical and experimental rheumatology
Published: January 14, 2015
Last Updated: 09/26/2026